社区
首页
集团介绍
社区
资讯
行情
学堂
TigerGPT
登录
注册
Zawzaw
IP属地：未知
+关注
帖子 · 14
帖子 · 14
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Zawzaw
Zawzaw
·
2021-08-25
Up a lot
看
547
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Zawzaw
Zawzaw
·
2021-07-22
Price down
看
1,011
回复
评论
点赞
1
编组 21备份 2
分享
举报
Zawzaw
Zawzaw
·
2021-07-22
Wow
EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection
FormerPepsiCo Inc PEPpresident andApple IncAAPLCEOJohn Sculleyraved about Celularity IncCELUMonday o
EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection
看
604
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Zawzaw
Zawzaw
·
2021-07-22
Wow
非常抱歉，此主贴已删除
看
792
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Zawzaw
Zawzaw
·
2021-07-22
Good
Premarket Movers Wednesday: Chembio, NeuroMetrix, Johnson & Johnson
Stocks moving in premarket trading Wednesday include Chembio, NeuroMetrix, Johnson & Johnson, Coke a
Premarket Movers Wednesday: Chembio, NeuroMetrix, Johnson & Johnson
看
1,044
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Zawzaw
Zawzaw
·
2021-07-22
$Pitney Bowes(PBI)$
[Speechless]
看
617
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Zawzaw
Zawzaw
·
2021-07-21
Good
非常抱歉，此主贴已删除
看
693
回复
2
点赞
3
编组 21备份 2
分享
举报
Zawzaw
Zawzaw
·
2021-07-21
[Smile]
EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection
FormerPepsiCo Inc PEPpresident andApple IncAAPLCEOJohn Sculleyraved about Celularity IncCELUMonday o
EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection
看
632
回复
评论
点赞
4
编组 21备份 2
分享
举报
Zawzaw
Zawzaw
·
2021-07-15
Ok
非常抱歉，此主贴已删除
看
512
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Zawzaw
Zawzaw
·
2021-07-15
[Strong]
U.S. weekly jobless claims total 360,000, as expected
New weekly jobless claims fell to the lowest level since March 2020, closing back in on pre-pandemic
U.S. weekly jobless claims total 360,000, as expected
看
661
回复
评论
点赞
2
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3585964534520423","uuid":"3585964534520423","gmtCreate":1622870510055,"gmtModify":1622870510055,"name":"Zawzaw","pinyin":"zawzaw","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":11,"tweetSize":14,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":837481164,"gmtCreate":1629905289158,"gmtModify":1631891368365,"author":{"id":"3585964534520423","authorId":"3585964534520423","name":"Zawzaw","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585964534520423","authorIdStr":"3585964534520423"},"themes":[],"htmlText":"Up a lot ","listText":"Up a lot ","text":"Up a lot","images":[{"img":"https://static.tigerbbs.com/fb9d8c6fc0cdd61d6653502c0c667d13","width":"1125","height":"2878"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/837481164","isVote":1,"tweetType":1,"viewCount":547,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":172539658,"gmtCreate":1626965386874,"gmtModify":1631891368369,"author":{"id":"3585964534520423","authorId":"3585964534520423","name":"Zawzaw","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585964534520423","authorIdStr":"3585964534520423"},"themes":[],"htmlText":"Price down","listText":"Price down","text":"Price down","images":[{"img":"https://static.tigerbbs.com/a6d847b7843933230be059042f7756f1","width":"1125","height":"2878"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/172539658","isVote":1,"tweetType":1,"viewCount":1011,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":176234113,"gmtCreate":1626885910532,"gmtModify":1631891368369,"author":{"id":"3585964534520423","authorId":"3585964534520423","name":"Zawzaw","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585964534520423","authorIdStr":"3585964534520423"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/176234113","repostId":"1121414767","repostType":4,"repost":{"id":"1121414767","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1626871035,"share":"https://www.laohu8.com/m/news/1121414767?lang=&edition=full","pubTime":"2021-07-21 20:37","market":"us","language":"en","title":"EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection","url":"https://stock-news.laohu8.com/highlight/detail?id=1121414767","media":"Benzinga","summary":"FormerPepsiCo Inc PEPpresident andApple IncAAPLCEOJohn Sculleyraved about Celularity IncCELUMonday o","content":"<p>Former<b>PepsiCo Inc</b> PEPpresident and<b>Apple Inc</b>AAPLCEO<b>John Sculley</b>raved about <b>Celularity Inc</b>CELUMonday on Benzinga's YouTube show \"Power Hour.\"</p>\n<p>Celularity founder and CEO<b>Robert Harini</b>appeared on \"Power Hour\" for an exclusive interview Tuesday.</p>\n<p>Celularity went public via special purpose acquisition company <a href=\"https://laohu8.com/S/GXGX\">GX Acquisition</a> Corp. on July 16.</p>\n<p>Celularity focuses on delivering cellular medicines derived from the postpartum human placenta, Harini told Benzinga.</p>\n<p>Sculley is a founding director and vice chairman of the board at Cellularity.</p>\n<p>Harini said he's fortunate to work on the noble pursuit of transforming living cells into medicine with Sculley. Harini went on to talk more about Sculley, an award he received from<b>Pope Francis</b>and more.</p>\n<p><b>Key Highlights:</b></p>\n<ul>\n <li>The human placenta is \"nature's stem cell factory.\" Celularity uses the placenta to produce a product that is \"<a href=\"https://laohu8.com/S/AONE.U\">one</a>-size-fits-all.\"</li>\n <li>Celularity uses<b>Palantir Technologies Inc</b>PLTR 0.05%to enhance the quality of its products. Palantir sought out the partnership because of its deep interest in biological science and the health care industry.</li>\n <li>One great future opportunity will be to find ways to mitigate the degenerative changes that occur with aging. Cellular biology is \"here to stay.\"</li>\n <li>Harini developed his passion after being intrigued by the possibility for stem cells to be used as a tool for restoring function in a damaged brain.</li>\n <li>He believes Celularity's future products will have the quality and economics to help lead the industry.</li>\n</ul>\n<p><b>CELU Price Action:</b>Celularity shares gained 4.05% Tuesday, closing at $21.85.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-07-21 20:37</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Former<b>PepsiCo Inc</b> PEPpresident and<b>Apple Inc</b>AAPLCEO<b>John Sculley</b>raved about <b>Celularity Inc</b>CELUMonday on Benzinga's YouTube show \"Power Hour.\"</p>\n<p>Celularity founder and CEO<b>Robert Harini</b>appeared on \"Power Hour\" for an exclusive interview Tuesday.</p>\n<p>Celularity went public via special purpose acquisition company <a href=\"https://laohu8.com/S/GXGX\">GX Acquisition</a> Corp. on July 16.</p>\n<p>Celularity focuses on delivering cellular medicines derived from the postpartum human placenta, Harini told Benzinga.</p>\n<p>Sculley is a founding director and vice chairman of the board at Cellularity.</p>\n<p>Harini said he's fortunate to work on the noble pursuit of transforming living cells into medicine with Sculley. Harini went on to talk more about Sculley, an award he received from<b>Pope Francis</b>and more.</p>\n<p><b>Key Highlights:</b></p>\n<ul>\n <li>The human placenta is \"nature's stem cell factory.\" Celularity uses the placenta to produce a product that is \"<a href=\"https://laohu8.com/S/AONE.U\">one</a>-size-fits-all.\"</li>\n <li>Celularity uses<b>Palantir Technologies Inc</b>PLTR 0.05%to enhance the quality of its products. Palantir sought out the partnership because of its deep interest in biological science and the health care industry.</li>\n <li>One great future opportunity will be to find ways to mitigate the degenerative changes that occur with aging. Cellular biology is \"here to stay.\"</li>\n <li>Harini developed his passion after being intrigued by the possibility for stem cells to be used as a tool for restoring function in a damaged brain.</li>\n <li>He believes Celularity's future products will have the quality and economics to help lead the industry.</li>\n</ul>\n<p><b>CELU Price Action:</b>Celularity shares gained 4.05% Tuesday, closing at $21.85.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121414767","content_text":"FormerPepsiCo Inc PEPpresident andApple IncAAPLCEOJohn Sculleyraved about Celularity IncCELUMonday on Benzinga's YouTube show \"Power Hour.\"\nCelularity founder and CEORobert Hariniappeared on \"Power Hour\" for an exclusive interview Tuesday.\nCelularity went public via special purpose acquisition company GX Acquisition Corp. on July 16.\nCelularity focuses on delivering cellular medicines derived from the postpartum human placenta, Harini told Benzinga.\nSculley is a founding director and vice chairman of the board at Cellularity.\nHarini said he's fortunate to work on the noble pursuit of transforming living cells into medicine with Sculley. Harini went on to talk more about Sculley, an award he received fromPope Francisand more.\nKey Highlights:\n\nThe human placenta is \"nature's stem cell factory.\" Celularity uses the placenta to produce a product that is \"one-size-fits-all.\"\nCelularity usesPalantir Technologies IncPLTR 0.05%to enhance the quality of its products. Palantir sought out the partnership because of its deep interest in biological science and the health care industry.\nOne great future opportunity will be to find ways to mitigate the degenerative changes that occur with aging. Cellular biology is \"here to stay.\"\nHarini developed his passion after being intrigued by the possibility for stem cells to be used as a tool for restoring function in a damaged brain.\nHe believes Celularity's future products will have the quality and economics to help lead the industry.\n\nCELU Price Action:Celularity shares gained 4.05% Tuesday, closing at $21.85.","news_type":1},"isVote":1,"tweetType":1,"viewCount":604,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176235551,"gmtCreate":1626885867973,"gmtModify":1631891368372,"author":{"id":"3585964534520423","authorId":"3585964534520423","name":"Zawzaw","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585964534520423","authorIdStr":"3585964534520423"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/176235551","repostId":"1172321314","repostType":4,"isVote":1,"tweetType":1,"viewCount":792,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176235884,"gmtCreate":1626885809848,"gmtModify":1631891368375,"author":{"id":"3585964534520423","authorId":"3585964534520423","name":"Zawzaw","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585964534520423","authorIdStr":"3585964534520423"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/176235884","repostId":"1149538891","repostType":4,"repost":{"id":"1149538891","kind":"news","pubTimestamp":1626873436,"share":"https://www.laohu8.com/m/news/1149538891?lang=&edition=full","pubTime":"2021-07-21 21:17","market":"us","language":"en","title":"Premarket Movers Wednesday: Chembio, NeuroMetrix, Johnson & Johnson","url":"https://stock-news.laohu8.com/highlight/detail?id=1149538891","media":"The Street","summary":"Stocks moving in premarket trading Wednesday include Chembio, NeuroMetrix, Johnson & Johnson, Coke a","content":"<blockquote>\n Stocks moving in premarket trading Wednesday include Chembio, <a href=\"https://laohu8.com/S/NURO\">NeuroMetrix</a>, Johnson & Johnson, Coke and Verizon.\n</blockquote>\n<p>Stock futureswere higher Wednesday, potentially extending a rebound on Wall Street, as investors focused on earnings and the economic impact of rising coronavirus infections across the globe.</p>\n<p>Here are some of the top movers during premarket trading on Wednesday:</p>\n<p><b>1. <a href=\"https://laohu8.com/S/CEMI\">Chembio Diagnostics</a> - Up 110%</b></p>\n<p>Chembio Diagnostics (<b>CEMI</b>) -Get Report doubled after the diagnostic-test maker said it received a $28.3 million order from Bio-Manguinhos for its DPP SARS-CoV-2 Antigen tests for Brazil’s Ministry of Health to address the COVID-19 pandemic. The test is designed to detect the SARS-CoV-2 antigen, which indicates an active COVID-19 infection, in 20 minutes using a nasal swab.</p>\n<p><b>2. NeuroMetrix - Up 31%</b></p>\n<p>Shares of NeuroMetrix (<b>NURO</b>) -Get Report continued to climb after the U.S. Food and Drug Administration gavea breakthrough designation to the biopharma's Quell device for treating fibromyalgia in adults. Quell is a non-invasive nerve-stimulation device, the company said.</p>\n<p><b>3. Johnson & Johnson - Up 1%</b></p>\n<p>Johnson & Johnson (<b>JNJ</b>) -Get Report rose after pharmaceutical and health products company postedstronger-than-expectedsecond-quarter earnings, while boosting its full-year profit forecast. Rebounds in pharmaceutical and consumer health sales boosted the top and bottom lines.</p>\n<p><b>4. Coca-Cola - Up 2.4%</b></p>\n<p>Shares of Coca-Cola (<b>KO</b>) -Get Report jumped after the soft drinks titan reported better-than-expectedsecond-quarter earnings and lifted its full-year profit forecast. The report reflects major economies worldwide continuing to reopen restaurants, sports venues and movie theaters following pandemic-forced shutdowns.</p>\n<p><b>5. Verizon - Up 1.7%</b></p>\n<p>Verizon(<b>VZ</b>) -Get Reportshares rose after the telecom-services giant beat Wall Street's second-quarter earnings expectations, sparked by higher demand for 5G-related services and devices. Verizon added 275,000 postpaid phone subscribers in the second quarter, above FactSet estimates of 174,800, according to Reuters.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Premarket Movers Wednesday: Chembio, NeuroMetrix, Johnson & Johnson</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPremarket Movers Wednesday: Chembio, NeuroMetrix, Johnson & Johnson\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-21 21:17 GMT+8 <a href=https://www.thestreet.com/investing/premarket-movers-wednesday-chembio-neurometrix-johnson-and-johnson><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stocks moving in premarket trading Wednesday include Chembio, NeuroMetrix, Johnson & Johnson, Coke and Verizon.\n\nStock futureswere higher Wednesday, potentially extending a rebound on Wall Street, as ...</p>\n\n<a href=\"https://www.thestreet.com/investing/premarket-movers-wednesday-chembio-neurometrix-johnson-and-johnson\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NURO":"NeuroMetrix","VZ":"威瑞森","JNJ":"强生","KO":"可口可乐","CEMI":"Chembio Diagnostics"},"source_url":"https://www.thestreet.com/investing/premarket-movers-wednesday-chembio-neurometrix-johnson-and-johnson","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149538891","content_text":"Stocks moving in premarket trading Wednesday include Chembio, NeuroMetrix, Johnson & Johnson, Coke and Verizon.\n\nStock futureswere higher Wednesday, potentially extending a rebound on Wall Street, as investors focused on earnings and the economic impact of rising coronavirus infections across the globe.\nHere are some of the top movers during premarket trading on Wednesday:\n1. Chembio Diagnostics - Up 110%\nChembio Diagnostics (CEMI) -Get Report doubled after the diagnostic-test maker said it received a $28.3 million order from Bio-Manguinhos for its DPP SARS-CoV-2 Antigen tests for Brazil’s Ministry of Health to address the COVID-19 pandemic. The test is designed to detect the SARS-CoV-2 antigen, which indicates an active COVID-19 infection, in 20 minutes using a nasal swab.\n2. NeuroMetrix - Up 31%\nShares of NeuroMetrix (NURO) -Get Report continued to climb after the U.S. Food and Drug Administration gavea breakthrough designation to the biopharma's Quell device for treating fibromyalgia in adults. Quell is a non-invasive nerve-stimulation device, the company said.\n3. Johnson & Johnson - Up 1%\nJohnson & Johnson (JNJ) -Get Report rose after pharmaceutical and health products company postedstronger-than-expectedsecond-quarter earnings, while boosting its full-year profit forecast. Rebounds in pharmaceutical and consumer health sales boosted the top and bottom lines.\n4. Coca-Cola - Up 2.4%\nShares of Coca-Cola (KO) -Get Report jumped after the soft drinks titan reported better-than-expectedsecond-quarter earnings and lifted its full-year profit forecast. The report reflects major economies worldwide continuing to reopen restaurants, sports venues and movie theaters following pandemic-forced shutdowns.\n5. Verizon - Up 1.7%\nVerizon(VZ) -Get Reportshares rose after the telecom-services giant beat Wall Street's second-quarter earnings expectations, sparked by higher demand for 5G-related services and devices. Verizon added 275,000 postpaid phone subscribers in the second quarter, above FactSet estimates of 174,800, according to Reuters.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1044,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176232508,"gmtCreate":1626885733104,"gmtModify":1631891259080,"author":{"id":"3585964534520423","authorId":"3585964534520423","name":"Zawzaw","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585964534520423","authorIdStr":"3585964534520423"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PBI\">$Pitney Bowes(PBI)$</a>[Speechless] ","listText":"<a href=\"https://laohu8.com/S/PBI\">$Pitney Bowes(PBI)$</a>[Speechless] ","text":"$Pitney Bowes(PBI)$[Speechless]","images":[{"img":"https://static.tigerbbs.com/918687fc7c52470d45aca9f59122d21f","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/176232508","isVote":1,"tweetType":1,"viewCount":617,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":176117970,"gmtCreate":1626871307290,"gmtModify":1631891368379,"author":{"id":"3585964534520423","authorId":"3585964534520423","name":"Zawzaw","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585964534520423","authorIdStr":"3585964534520423"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/176117970","repostId":"2153964348","repostType":4,"isVote":1,"tweetType":1,"viewCount":693,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176114482,"gmtCreate":1626871277346,"gmtModify":1631891368388,"author":{"id":"3585964534520423","authorId":"3585964534520423","name":"Zawzaw","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585964534520423","authorIdStr":"3585964534520423"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/176114482","repostId":"1121414767","repostType":4,"repost":{"id":"1121414767","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1626871035,"share":"https://www.laohu8.com/m/news/1121414767?lang=&edition=full","pubTime":"2021-07-21 20:37","market":"us","language":"en","title":"EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection","url":"https://stock-news.laohu8.com/highlight/detail?id=1121414767","media":"Benzinga","summary":"FormerPepsiCo Inc PEPpresident andApple IncAAPLCEOJohn Sculleyraved about Celularity IncCELUMonday o","content":"<p>Former<b>PepsiCo Inc</b> PEPpresident and<b>Apple Inc</b>AAPLCEO<b>John Sculley</b>raved about <b>Celularity Inc</b>CELUMonday on Benzinga's YouTube show \"Power Hour.\"</p>\n<p>Celularity founder and CEO<b>Robert Harini</b>appeared on \"Power Hour\" for an exclusive interview Tuesday.</p>\n<p>Celularity went public via special purpose acquisition company <a href=\"https://laohu8.com/S/GXGX\">GX Acquisition</a> Corp. on July 16.</p>\n<p>Celularity focuses on delivering cellular medicines derived from the postpartum human placenta, Harini told Benzinga.</p>\n<p>Sculley is a founding director and vice chairman of the board at Cellularity.</p>\n<p>Harini said he's fortunate to work on the noble pursuit of transforming living cells into medicine with Sculley. Harini went on to talk more about Sculley, an award he received from<b>Pope Francis</b>and more.</p>\n<p><b>Key Highlights:</b></p>\n<ul>\n <li>The human placenta is \"nature's stem cell factory.\" Celularity uses the placenta to produce a product that is \"<a href=\"https://laohu8.com/S/AONE.U\">one</a>-size-fits-all.\"</li>\n <li>Celularity uses<b>Palantir Technologies Inc</b>PLTR 0.05%to enhance the quality of its products. Palantir sought out the partnership because of its deep interest in biological science and the health care industry.</li>\n <li>One great future opportunity will be to find ways to mitigate the degenerative changes that occur with aging. Cellular biology is \"here to stay.\"</li>\n <li>Harini developed his passion after being intrigued by the possibility for stem cells to be used as a tool for restoring function in a damaged brain.</li>\n <li>He believes Celularity's future products will have the quality and economics to help lead the industry.</li>\n</ul>\n<p><b>CELU Price Action:</b>Celularity shares gained 4.05% Tuesday, closing at $21.85.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-07-21 20:37</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Former<b>PepsiCo Inc</b> PEPpresident and<b>Apple Inc</b>AAPLCEO<b>John Sculley</b>raved about <b>Celularity Inc</b>CELUMonday on Benzinga's YouTube show \"Power Hour.\"</p>\n<p>Celularity founder and CEO<b>Robert Harini</b>appeared on \"Power Hour\" for an exclusive interview Tuesday.</p>\n<p>Celularity went public via special purpose acquisition company <a href=\"https://laohu8.com/S/GXGX\">GX Acquisition</a> Corp. on July 16.</p>\n<p>Celularity focuses on delivering cellular medicines derived from the postpartum human placenta, Harini told Benzinga.</p>\n<p>Sculley is a founding director and vice chairman of the board at Cellularity.</p>\n<p>Harini said he's fortunate to work on the noble pursuit of transforming living cells into medicine with Sculley. Harini went on to talk more about Sculley, an award he received from<b>Pope Francis</b>and more.</p>\n<p><b>Key Highlights:</b></p>\n<ul>\n <li>The human placenta is \"nature's stem cell factory.\" Celularity uses the placenta to produce a product that is \"<a href=\"https://laohu8.com/S/AONE.U\">one</a>-size-fits-all.\"</li>\n <li>Celularity uses<b>Palantir Technologies Inc</b>PLTR 0.05%to enhance the quality of its products. Palantir sought out the partnership because of its deep interest in biological science and the health care industry.</li>\n <li>One great future opportunity will be to find ways to mitigate the degenerative changes that occur with aging. Cellular biology is \"here to stay.\"</li>\n <li>Harini developed his passion after being intrigued by the possibility for stem cells to be used as a tool for restoring function in a damaged brain.</li>\n <li>He believes Celularity's future products will have the quality and economics to help lead the industry.</li>\n</ul>\n<p><b>CELU Price Action:</b>Celularity shares gained 4.05% Tuesday, closing at $21.85.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121414767","content_text":"FormerPepsiCo Inc PEPpresident andApple IncAAPLCEOJohn Sculleyraved about Celularity IncCELUMonday on Benzinga's YouTube show \"Power Hour.\"\nCelularity founder and CEORobert Hariniappeared on \"Power Hour\" for an exclusive interview Tuesday.\nCelularity went public via special purpose acquisition company GX Acquisition Corp. on July 16.\nCelularity focuses on delivering cellular medicines derived from the postpartum human placenta, Harini told Benzinga.\nSculley is a founding director and vice chairman of the board at Cellularity.\nHarini said he's fortunate to work on the noble pursuit of transforming living cells into medicine with Sculley. Harini went on to talk more about Sculley, an award he received fromPope Francisand more.\nKey Highlights:\n\nThe human placenta is \"nature's stem cell factory.\" Celularity uses the placenta to produce a product that is \"one-size-fits-all.\"\nCelularity usesPalantir Technologies IncPLTR 0.05%to enhance the quality of its products. Palantir sought out the partnership because of its deep interest in biological science and the health care industry.\nOne great future opportunity will be to find ways to mitigate the degenerative changes that occur with aging. Cellular biology is \"here to stay.\"\nHarini developed his passion after being intrigued by the possibility for stem cells to be used as a tool for restoring function in a damaged brain.\nHe believes Celularity's future products will have the quality and economics to help lead the industry.\n\nCELU Price Action:Celularity shares gained 4.05% Tuesday, closing at $21.85.","news_type":1},"isVote":1,"tweetType":1,"viewCount":632,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":147611703,"gmtCreate":1626356046602,"gmtModify":1631891368389,"author":{"id":"3585964534520423","authorId":"3585964534520423","name":"Zawzaw","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585964534520423","authorIdStr":"3585964534520423"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/147611703","repostId":"2151299547","repostType":4,"isVote":1,"tweetType":1,"viewCount":512,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":147619868,"gmtCreate":1626355975754,"gmtModify":1631891368389,"author":{"id":"3585964534520423","authorId":"3585964534520423","name":"Zawzaw","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585964534520423","authorIdStr":"3585964534520423"},"themes":[],"htmlText":"[Strong] ","listText":"[Strong] ","text":"[Strong]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/147619868","repostId":"1140240161","repostType":4,"repost":{"id":"1140240161","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626352521,"share":"https://www.laohu8.com/m/news/1140240161?lang=&edition=full","pubTime":"2021-07-15 20:35","market":"us","language":"en","title":"U.S. weekly jobless claims total 360,000, as expected","url":"https://stock-news.laohu8.com/highlight/detail?id=1140240161","media":"Tiger Newspress","summary":"New weekly jobless claims fell to the lowest level since March 2020, closing back in on pre-pandemic","content":"<p>New weekly jobless claims fell to the lowest level since March 2020, closing back in on pre-pandemic levels as the rate of new joblessness slowed further.</p>\n<p>The Department of Labor released its weekly report on new jobless claims Thursday at 8:30 a.m. ET. Here were the main metrics from the report, compared to consensus data compiled by Bloomberg:</p>\n<ul>\n <li><p><b>Initial jobless claims, week ended July 10:</b>360,000 vs. 350,000 expected and 373,000 during prior week</p></li>\n <li><p><b>Continuing claims, week ended July 3:</b>3.241 million vs. 3.300 million expected and 3.339 million during prior week</p></li>\n</ul>\n<p>Initial unemployment claims extended a months-long downward trend and came in below the psychologically important 400,000 level for a third straight week. During the comparable week in mid-July last year, new filings totaled 1.5 million.</p>\n<p>Markets reacted little to the claims news, with stock market futures pointing lower and government bond yields edging down following the release.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. weekly jobless claims total 360,000, as expected</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. weekly jobless claims total 360,000, as expected\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-15 20:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>New weekly jobless claims fell to the lowest level since March 2020, closing back in on pre-pandemic levels as the rate of new joblessness slowed further.</p>\n<p>The Department of Labor released its weekly report on new jobless claims Thursday at 8:30 a.m. ET. Here were the main metrics from the report, compared to consensus data compiled by Bloomberg:</p>\n<ul>\n <li><p><b>Initial jobless claims, week ended July 10:</b>360,000 vs. 350,000 expected and 373,000 during prior week</p></li>\n <li><p><b>Continuing claims, week ended July 3:</b>3.241 million vs. 3.300 million expected and 3.339 million during prior week</p></li>\n</ul>\n<p>Initial unemployment claims extended a months-long downward trend and came in below the psychologically important 400,000 level for a third straight week. During the comparable week in mid-July last year, new filings totaled 1.5 million.</p>\n<p>Markets reacted little to the claims news, with stock market futures pointing lower and government bond yields edging down following the release.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140240161","content_text":"New weekly jobless claims fell to the lowest level since March 2020, closing back in on pre-pandemic levels as the rate of new joblessness slowed further.\nThe Department of Labor released its weekly report on new jobless claims Thursday at 8:30 a.m. ET. Here were the main metrics from the report, compared to consensus data compiled by Bloomberg:\n\nInitial jobless claims, week ended July 10:360,000 vs. 350,000 expected and 373,000 during prior week\nContinuing claims, week ended July 3:3.241 million vs. 3.300 million expected and 3.339 million during prior week\n\nInitial unemployment claims extended a months-long downward trend and came in below the psychologically important 400,000 level for a third straight week. During the comparable week in mid-July last year, new filings totaled 1.5 million.\nMarkets reacted little to the claims news, with stock market futures pointing lower and government bond yields edging down following the release.","news_type":1},"isVote":1,"tweetType":1,"viewCount":661,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}